Gene inoculation generates immune responses against human immunodeficiency virus type 1
about
Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite proteinIncreased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageProtection against malaria by immunization with plasmid DNA encoding circumsporozoite proteinDNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculationsPreferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunizationPotent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationDNA immunization as a technology platform for monoclonal antibody inductionSynthetic DNA vaccine strategies against persistent viral infectionsEnhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexesExpression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization.DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in miceInduction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes.DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsidImmune responses to plasmid DNA encoding the hepatitis C virus core proteinImmunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection modeProphylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.DNA vaccine for cancer immunotherapyMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesAmiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cellsProgress in HIV vaccine research.Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).Prospects for control of emerging infectious diseases with plasmid DNA vaccines.Ultrasonic synthetic technique to manufacture a pHEMA nanopolymeric-based vaccine against the H6N2 avian influenza virus: a preliminary investigation.Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.Genes that induce immunity--DNA vaccines.In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones.Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.DNA vaccines: developing new strategies against cancer.Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvantsDeviation of the allergic IgE to an IgG response by gene immunotherapy.Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boostIncreasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct.Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression.Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in miceIncrease of skeletal muscle relaxation speed by direct injection of parvalbumin cDNA.
P2860
Q24514954-7386F76F-A8B8-4AE2-B65C-F9D11E03225BQ24531468-7E8791F5-FC92-4838-8CDE-60C8C6EC9496Q24563514-D125CF79-833B-44B2-AAF4-B084E42A1227Q24563751-91BD0766-72FF-4092-9D49-F8AB703E912EQ24599495-33391F13-25F7-475B-A7AC-4484BD20CADCQ24646818-388035BC-D0B9-4B9E-A459-E03A266128BEQ26751432-A330405E-62E2-4ACA-8C4F-4F260CBC3A43Q27016078-7F85C684-CE1D-4088-B644-B78B537D328CQ27309096-93C0F4A1-EE3E-4EFC-8EB9-190DDD1E26EEQ27469367-2E451868-96A2-4EB3-BE1A-C2FD9B02BD21Q27469515-8EF9483D-B9D4-4572-BC17-B92DF23CCC90Q27469568-FE66E480-216F-45DB-BFE2-DA285123D128Q27480298-9EB907C4-39EA-4FBB-BA7C-35583633FA0CQ27480300-B1168980-D78F-4CE8-9FF6-885CCD58A739Q27480864-5A49C221-540D-4F34-89BB-B928AADCA247Q27488288-91B25405-63F7-446B-AF9D-3E76964C9928Q28080919-43525DBF-AC82-4A57-A849-8E262EFD7DCDQ28294355-430F4A8B-88CC-4699-A3B7-69A2F02B30E7Q28481556-238AC818-4BF6-4302-B3F4-E48BD67B863AQ30331429-5C071D62-CAEC-44D7-8135-F149EB0CD578Q30379200-796823BC-DF26-4C6B-8E53-70162F22068EQ30380454-6CA2A805-05EC-4D69-A453-E7DFE019986AQ30409922-3C0CA460-2B8D-49B1-AEA0-F18AB3911A95Q33586294-FB68C285-93A2-450F-A51C-05A6E4DC28C3Q33639596-326AACB2-0BEC-4164-B236-9CEADE8652DAQ33641393-0CAB4C72-859F-4E89-994D-386B9B2B365DQ33676884-ACB11332-0851-417E-8565-4278B3012D85Q33698112-9E6D4540-C3E5-4B45-BF45-5B729BC2B57DQ33756622-53985D14-DFFF-4E46-8BFD-01EDEF4357ECQ33784161-B78213BA-2480-46C6-8675-9A6FAF85C17CQ33785383-3C8A8DB5-2CC8-4524-B5E9-E6C41E547626Q33801810-95552BA7-0DB8-4E93-A46D-DDFE038619DAQ33805880-5549E3BE-6396-4651-9F32-7543A23A2526Q33809753-F52E6B7D-1205-40A0-9D30-B2AAF2566D1DQ33813173-4617AA0F-9B11-4987-881C-58AA37B80CC0Q33815062-A03BDB58-B08A-47DD-AC45-C37A14AF8808Q33822789-93595A19-16BE-4B12-9E10-97CECAA884EEQ33841686-829B5C57-DE24-45AE-85CA-9D338A968D0DQ34002455-B71049EA-A6AE-4174-BBC9-661844974632Q34133432-CCCC1F40-72DA-4672-9C6F-22E5F815F334
P2860
Gene inoculation generates immune responses against human immunodeficiency virus type 1
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Gene inoculation generates immune responses against human immunodeficiency virus type 1
@ast
Gene inoculation generates immune responses against human immunodeficiency virus type 1
@en
type
label
Gene inoculation generates immune responses against human immunodeficiency virus type 1
@ast
Gene inoculation generates immune responses against human immunodeficiency virus type 1
@en
prefLabel
Gene inoculation generates immune responses against human immunodeficiency virus type 1
@ast
Gene inoculation generates immune responses against human immunodeficiency virus type 1
@en
P2093
P2860
P356
P1476
Gene inoculation generates immune responses against human immunodeficiency virus type 1
@en
P2093
Agadjanyan MG
Srikantan V
Williams WV
P2860
P304
P356
10.1073/PNAS.90.9.4156
P407
P577
1993-05-01T00:00:00Z